Evaluation of phentermine and topiramate versus phentermine/topiramate extended‐release in obese adults

Abstract

PHEN/TPM ER demonstrated greater WL when used in combination than when used as monotherapies, suggesting enhanced ability of the combination formulation to induce WL at doses lower than with available monotherapies.